secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rubius Therapeutics, Inc. (—)
CIK:        0001709401
Form:       8-K
Filed at:   2022-12-21T23:59:59+00:00
Accession:  0001104659-22-129159
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.01
LLM model:  deepseek-v4-flash:cloud@v2

Rubius Therapeutics completes sale of Rhode Island manufacturing facility for $18.5M
--------------------------------------------------------------------------------

- Completed sale of real property in Smithfield, RI including manufacturing facility to DIV Acquisition V, LLC.
- Aggregate purchase price of $18,500,000 subject to adjustment.
- Sale previously announced in 8-K filed Dec 12, 2022.
- Proceeds use not specified; company retains Cambridge, MA headquarters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1709401/000110465922129159/0001104659-22-129159-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1709401/000110465922129159/tm2233241d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-129159

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer